M&T Bank’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

M&T Bank’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,948	Closed	-$1.38M	–	1694
2023 Q3	$1.38M	Sell	11,948 -3,942	-25%	-$424K	0.01%	729
2023 Q2	$1.63M	Sell	15,890 -554	-3%	-$58.4K	0.01%	711
2023 Q1	$1.79M	Sell	16,444 -5,183	-24%	-$573K	0.01%	662
2022 Q4	$2.46M	Buy	21,627 +283	+1%	+$23.5K	0.01%	561
2022 Q3	$1.32M	Sell	21,344 -22,969	-52%	-$1.6M	0.01%	729
2022 Q2	$2.35M	Buy	44,313 +13,092	+42%	+$1.24M	0.01%	523
2022 Q1	$3.29M	Buy	31,221 +1,577	+5%	+$154K	0.01%	442
2021 Q4	$3.19M	Sell	29,644 -391	-1%	-$42.7K	0.01%	461
2021 Q3	$3.29M	Sell	30,035 -1,294	-4%	-$134K	0.01%	451
2021 Q2	$2.94M	Sell	31,329 -13	-0%	-$1.2K	0.01%	486
2021 Q1	$2.88M	Buy	31,342 +22,908	+272%	+$1.93M	0.01%	474
2020 Q4	$616K	Buy	8,434 +457	+6%	+$34K	﹤0.01%	949
2020 Q3	$620K	Buy	7,977 +2,012	+34%	+$138K	﹤0.01%	879
2020 Q2	$331K	Buy	+5,965	New	+$255K	﹤0.01%	1141
2020 Q1	–	Sell	-5,935	Closed	-$215K	–	1737
2019 Q4	$215K	Buy	+5,935	New	+$182K	﹤0.01%	1237
2016 Q4	–	Sell	-15,035	Closed	-$273K	–	1785
2016 Q3	$273K	Buy	+15,035	New	+$294K	﹤0.01%	1342
2016 Q2	–	Sell	-15,016	Closed	-$248K	–	1800
2016 Q1	$248K	Sell	15,016 -21,155	-58%	-$370K	﹤0.01%	1369
2015 Q4	$784K	Buy	+36,171	New	+$704K	0.01%	896
2015 Q3	–	Sell	-6,203	Closed	-$215K	–	2110
2015 Q2	$215K	Sell	6,203 -3,835	-38%	-$117K	﹤0.01%	1733
2015 Q1	$260K	Buy	+10,038	New	+$184K	﹤0.01%	1567

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

M&T Bank's HZNP Position: Q4 2023 in Review

M&T Bank sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 11,948 shares — an estimated $1.38M sold.

M&T Bank first reported a position in HZNP in Q1 2015 and held it in 20 quarters. The position peaked at $3.29M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

M&T Bank reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
M&T Bank sold 11,948 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.38M.
M&T Bank first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2015 and held it in 20 quarters.
M&T Bank's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $3.29M in Q3 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on M&T Bank's 13F filing for Q4 2023, filed 6 Feb 2024.